X0306 4 2020-08-24 false 0001636422 Health Catalyst, Inc. HCAT 0001780980 Burton Daniel D. C/O HEALTH CATALYST, INC. 3165 MILLROCK DRIVE, #400 SALT LAKE CITY UT 84121 true true false false Chief Executive Officer Common Stock 2020-08-24 4 M false 98554.00 15.84 A 256054.00 D Common Stock 2020-08-24 4 M false 5465.00 10.80 A 261519.00 D Common Stock 2020-08-24 4 M false 20.00 6.24 A 261539.00 D Common Stock 2020-08-24 4 S false 1900.00 32.00 D 259639.00 D Common Stock 2020-08-24 4 S false 8301.00 31.18 D 251338.00 D Common Stock 2020-08-24 4 S false 93838.00 30.24 D 157500.00 D Common Stock 2020-08-25 4 M false 17013.00 15.84 A 174513.00 D Common Stock 2020-08-25 4 S false 6080.00 30.34 D 168433.00 D Common Stock 2020-08-25 4 S false 10933.00 30.88 D 157500.00 D Stock Option (Right to Buy) 15.84 2020-08-24 4 M false 98554.00 0.00 D 2029-02-05 Common Stock 98554.00 201194.00 D Stock Option (Right to Buy) 10.80 2020-08-24 4 M false 5465.00 0.00 D 2028-09-27 Common Stock 5465.00 401269.00 D Stock Option (Right to Buy) 6.24 2020-08-24 4 M false 20.00 0.00 D 2018-05-31 2024-06-12 Common Stock 20.00 0.00 D Stock Option (Right to Buy) 15.84 2020-08-25 4 M false 17013.00 0.00 D 2029-02-05 Common Stock 17013.00 184181.00 D The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. Represents the weighted average sale price of the shares sold ranging from $31.94 to $32.02 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $30.94 to $31.86 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $29.94 to $30.93 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $29.64 to $30.63 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $30.64 to $31.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) though (6). 25% of the 299,748 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. 25% of the 747,223 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. 25% of the 76,465 shares underlying the options vested in an annual installment on May 13, 2015 and the remaining balance vested in equal monthly installments until the option vested in full on May 13, 2018. /s/ Daniel Orenstein, as Attorney-in-Fact 2020-08-26